<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://nephrobesity.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://nephrobesity.com/studies/flow-semaglutide-ckd/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/select-kidney/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/essence-mash/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/summit-tirzepatide-hfpef/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/surpass4-tirzepatide-kidney/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/finerenone-fidelity/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/ckm-2026-guideline/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/kdigo-obesity-ckd/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/asn-obesity-guidance/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/kdigo-2024-ckd/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/org-pathology/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/retatrutide-triple-agonist/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url><url><loc>https://nephrobesity.com/studies/euglycemic-dka-sglt2/</loc><lastmod>2026-07-03T12:00:00+00:00</lastmod></url></urlset>
